RT Journal Article
SR Electronic
T1 Tertiary prevention and treatment of rheumatic heart disease: a National Heart, Lung, and Blood Institute working group summary
JF BMJ Global Health
JO BMJ Global Health
FD BMJ Publishing Group Ltd
SP e012355
DO 10.1136/bmjgh-2023-012355
VO 8
IS Suppl 9
A1 Vervoort, Dominique
A1 Yilgwan, Christopher Sabo
A1 Ansong, Annette
A1 Baumgartner, Jennifer N
A1 Bansal, Geetha
A1 Bukhman, Gene
A1 Cannon, Jeffrey W
A1 Cardarelli, Marcelo
A1 Cunningham, Madeleine W
A1 Fenton, Kathleen
A1 Green-Parker, Melissa
A1 Karthikeyan, Ganesan
A1 Masterson, Mary
A1 Maswime, Salome
A1 Mensah, George A
A1 Mocumbi, Ana
A1 Kpodonu, Jacques
A1 Okello, Emmy
A1 Remenyi, B
A1 Williams, Makeda
A1 Zühlke, Liesl J
A1 Sable, Craig
YR 2023
UL http://gh.bmj.com/content/8/Suppl_9/e012355.abstract
AB Although entirely preventable, rheumatic heart disease (RHD), a disease of poverty and social disadvantage resulting in high morbidity and mortality, remains an ever-present burden in low-income and middle-income countries (LMICs) and rural, remote, marginalised and disenfranchised populations within high-income countries. In late 2021, the National Heart, Lung, and Blood Institute convened a workshop to explore the current state of science, to identify basic science and clinical research priorities to support RHD eradication efforts worldwide. This was done through the inclusion of multidisciplinary global experts, including cardiovascular and non-cardiovascular specialists as well as health policy and health economics experts, many of whom also represented or closely worked with patient-family organisations and local governments. This report summarises findings from one of the four working groups, the Tertiary Prevention Working Group, that was charged with assessing the management of late complications of RHD, including surgical interventions for patients with RHD. Due to the high prevalence of RHD in LMICs, particular emphasis was made on gaining a better understanding of needs in the field from the perspectives of the patient, community, provider, health system and policy-maker. We outline priorities to support the development, and implementation of accessible, affordable and sustainable interventions in low-resource settings to manage RHD and related complications. These priorities and other interventions need to be adapted to and driven by local contexts and integrated into health systems to best meet the needs of local communities.No data are available.